TMEDRP: decoding tumor-intrinsic and microenvironmental signatures for clinical drug response prediction
TMEDRP is a novel two-stage learning framework that integrates tumor-intrinsic signatures and TME-specific components for enhanced clinical drug response prediction and exhibits promising zero-shot generalization across unseen cancer lineages and novel compounds, suggesting its robustness across diverse scenarios.